NCT01100281

Brief Summary

The capacity of concept formation is not well understood, even if a link is supposed with the functioning of the frontal lobes. Our aim is to better understand the cognitive mechanisms underlying this function and to try to correlate the performance with atrophy of the frontal lobe in neurodegenerative diseases involving this region (frontotemporal lobar degeneration and progressive supranuclear palsy).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 7, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 8, 2010

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

December 9, 2011

Status Verified

December 1, 2011

First QC Date

April 7, 2010

Last Update Submit

December 8, 2011

Conditions

Keywords

prefrontal cortex

Study Arms (3)

PSP (Progressive supranuclear palsy)

Behavioral: Neuropsychological examinationOther: MRI

FTD (Frontotemporal lobar degenerative)

Behavioral: Neuropsychological examinationOther: MRI

Alzheimer's disease

Behavioral: Neuropsychological examinationOther: MRI

Interventions

Examination including especially concept formation

Alzheimer's diseaseFTD (Frontotemporal lobar degenerative)PSP (Progressive supranuclear palsy)
MRIOTHER

MRI performed in T1-weighted three dimensional sequence

Alzheimer's diseaseFTD (Frontotemporal lobar degenerative)PSP (Progressive supranuclear palsy)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

3 groups including : PSP, FTD, AD

You may qualify if:

  • informed consent signed
  • MMSE\> 20
  • No contra indication to MRI

You may not qualify if:

  • MMSE\<20

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inserm U 975

Paris, 75013, France

Location

MeSH Terms

Interventions

Neuropsychological Tests

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Richard Levy, MD

    Institut National de la Santé Et de la Recherche Médicale, France

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2010

First Posted

April 8, 2010

Study Start

April 1, 2010

Study Completion

April 1, 2011

Last Updated

December 9, 2011

Record last verified: 2011-12

Locations